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IL-2 is responsible for T  cell proliferation after activation of the T  cell antigen 
receptor complex (1-4).  Detailed studies using freshly isolated lymphocytes and 
functional T  cell clones have led to the realization  that T  cell clonal expansion 
is a  complex phenomenon,  based on both autocrine and paracrine  mechanisms 
involving the  IL-2-R system (5-7). All T  cells respond to antigen activation by 
the expression of high-affinity, IL-2-specific membrane receptors (8-10), whereas 
only a proportion of antigen-stimulated  T  cells are triggered to produce detect- 
able amounts of IL-2. Most T  helper cells expressing the T4 surface glycoprotein 
(1 1,  12) are capable of proliferating  in an autocrine  fashion in response to the 
IL-2 that they themselves produce (3,  8-10).  In contrast,  the great majority of 
T  cells of the cytolytic subclass, which express the T8 surface glycoprotein (11, 
12), proliferate in a paracrine fashion, in response to the IL-2 produced by T4 + 
helper T  cells (3, 8-10). 
In view of the understanding that autocrine and paracrine  IL-2-R systems are 
responsible for T  cell clonal expansion,  feedback regulatory controls surely are 
operative  for  limiting  IL-2  responsiveness,  thereby ensuring  that  autonomous 
cell proliferation does not persist after antigen stimulation, and result in uncon- 
trolled neoplastic cell growth.  One facet of the  IL-2-R operational  mechanism 
that  serves  to  restrict  uncontrolled  autonomous  growth,  and  which  may  be 
unique to the immune system, relates to the antigen-dependency of the response: 
IL-2-R expression is transient,  and quite dependent on antigen, so that upon its 
removal,  IL-2-R  decline  gradually  and  eventually  disappear  (5).  As  a  conse- 
quence, the proliferative rate of the cell population  diminishes,  and eventually 
all  of the cells reaccumulate in the resting (Go) phase of the cell cycle. Another 
mechanism that facilitates the disappearance of IL-2-R was recently revealed via 
IL-2-R  turnover  studies.  In  effect,  IL-2  itself regulates  its  growth-promoting 
effects by a  novel mechanism;  one that  leads to an  IL-2-promoted accelerated 
disappearance  of biologically relevant,  high-affinity  IL-2-R,  and  their  replace- 
ment by very low-affinity  IL-2  binding  sites that  do not  mediate  T  cell cycle 
progression (13).  Consequently, the removal of antigen and the IL-2-promoted 
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switch from high- to low-affinity IL-2-R both operate to restrain T  cell  clonal 
expansion via the regulation of IL-2-R expression. 
Soon after the discovery that lymphocyte-conditioned medium supports  the 
long-term growth of human T cells (1), it was found that antigen-specific cytolytic 
T  cells  could be  selected  (2)  and  cloned  (14)  using similar methods.  A  high 
proportion of clones (80%) proved to be of the cytolytic subclass (14).  Although 
cytolytic T cells could have been selected by the conditions used for their growth 
and clonal isolation, the mechanism responsible for this phenomenon and the 
immunologic or biologic significance attributable to the observation remained 
obscure. However, in the course of recent experiments exploring the regulation 
of IL-2-R expression by human peripheral T  cells,  we found that T8 + cells also 
predominate after only a  short-term (14-d)  IL-2-dependent expansion culture. 
This observation was reminiscent of the high frequency of cytolytic T  cell clones 
isolated after long-term culture in lymphocyte-conditioned medium. As we did 
not expect that T4 + cells could differ from T8 + cells with respect to the IL-2-R 
system, we designed several experimental approaches to characterize the phe- 
nomenon. 
Using freshly isolated human peripheral  mononuclear cells  stimulated poly- 
clonally with anti-T3 and cultured using homogeneous immunoaffinity-purified 
IL-2, we found that T4  + cells became refractory to the growth-promoting effects 
of IL-2 even though T8 + cells continued to proliferate. Since the loss of T4  + cell 
IL-2 responsiveness was not attributable to suppression by T8 + cells,  nor to the 
number, affinity, or recognizable functional capacities of IL-2-R expressed,  it 
appears likely that a unique mechanism renders T4  + cells unresponsive to IL-2, 
thereby curtailing IL-2-dependent clonal expansion of T4  + cells.  Accordingly, 
three mechanisms are now identifiable that inevitably make for the cessation of 
T4 + cell autocrine growth: two are mediated via the control of IL-2-R expression, 
whereas the third level of regulation is  IL-2-R-independent and restricted to 
T4 + cells. 
Materials and Methods 
Antibodies  and  Reagents.  Anti-T4a  (19  Thy  507  [IgG2]) and  anti-T8c  (7Pt  3F9 
[IgG~]) (15) were kindly provided by Dr. Ellis Reinherz  (Dana-Farber Cancer  Institute, 
Boston,  MA). OKT-3  was purchased  from Ortho Pharmaceutical  Corp.,  Raritan,  NJ. 
Phorbol-12,13-dibutyrate  (Pdbu) ~  (Consolidated Midland Corp., Brewster, NY) was used 
in some experiments  to reactivate IL-2-R expression. 
Cell Cultures.  Human peripheral mononuclear cells (PMC), isolated by FicolI-Hypaque 
discontinuous gradient centrifugation, were cultured in a humidified atmosphere  of 5% 
CO2 in air in RPMI 1640 medium (Gibco Laboratories, Grand Island, NY) supplemented 
with  10%  heat-inactivated  (56°C,  30 min) FCS (Sterile Systems, Inc.,  Logan,  UT),  50 
U/ml penicillin, 50 #g/ml gentamicin,  200 ug/ml L-glutamine, 5 #g/ml insulin, 6 ~g/ml 
transferrin, and 5 ng/ml selanous acid (ITS;  Collaborative  Research,  Inc.,  Lexington, 
MA). 
The murine IL-2-dependent  cytolytic T  lymphocyte line CTLL-2 (subclone 15G) was 
maintained in Iscove's modified DMEM as described previously (14). 
Selective Depletion of T Cell Subpopulations by mAb plus Complement.  To separate PMC 
7  into individual subpopulations, cells were resuspended  (10  cells/ml) in anti-T4a or anti- 
i Abbreviations  used in  this paper:  ATL, adult T  cell leukemia; HTLV, human T  lymphotrophic 
virus; Pdbu, phorbol-!  2,13-dibutyrate; PI, propidium iodide; PMC, peripheral mononuclear  cell. 272  REGULATION  OF  T  CELL  AUTOCRINE GROWTH 
T8c at a  1:800 dilution  of ascites fluid, and incubated,  with constant rotation, at room 
temperature for 1.5  h. Subsequently, the cells were sedimented by centrifugation. As a 
source of complement,  Low-Tox-M rabbit complement (1  m[, diluted  1:3;  Cedarlane 
Laboratories, Ltdl, Hornby, Ontario, Canada) was added, and ceils were incubated for 1 
h at 37°C. Viable cells were isolated by Ficoll-Hypaque discontinuous gradient centrifu- 
gation,  and  purity  was determined  by cytofluorographic analysis. The viable T4 + cell 
populations contained <5%  T8  + cells,  and  T8  + cell populations  manifested <4%  T4  + 
cells. After 72 h of culture, the cells were routinely reexposed to antibody and complement 
as  described  here;  after  this  second  treatment,  contaminating  cells  of the  respective 
subpopulations were no longer evident. 
Production and Preparation  of Affinity-purified  IL-2.  Jurkat subclone 6.8 was induced 
to produce IL-2 as described previously (16,  17). Unlabeled and biosynthetically radiola- 
beled [aH]leu,lys-IL-2 were purified from culture supernatants by a one-step purification 
protocol using an immunoaffinity column constructed with an IgG2a mAb reactive with 
1L-2 (designated DMS-3), described in detail elsewhere (16,  17). The eluted material was 
comprised of a single protein (Mr  15,500),  as determined by SDS-PAGE, reverse-phase 
liquid chromatography, and amino-terminal amino acid sequence analysis (17). 
The specific activity of radiolabeled IL-2 was determined by correlating radioactivity 
with biologic activity (18). Biologic activity and protein mass were determined on homo- 
geneous, IL-2, kindly supplied by Dr. K. Kato, Takeda Chemical Industries, Ltd., Osaka, 
Japan  (19).  Using  this  preparation as a  standard,  previous calculations  (16) of protein 
concentration and biologic activity were found to overestimated fourfold. The specific 
activity of [3H]leu,lys-IL-2 was calculated as 377,600 dpm/pmol. 
IL-2 Biological Activity.  IL-2 activity was determined as previously described (18), by 
the  IL-2 concentration-dependent  stimulation  of proliferation of a  cloned  CTLL (14). 
CTLL proliferation, monitored by [3H]TdR incorporation (2.0 #Ci/ml; sp act, 1.9 Ci/mM; 
Schwartz/Mann  Div.,  Becton-Dickinson  and  Co.,  Orangeburg,  NY),  was  determined 
during the last 4 h of a 24-h culture period in the presence of serial twofold dilutions of 
the standard  r  IL-2 preparation (19) and  the experimental sample. The dilutions  that 
yielded  50%  of maximal  CTLL  [3H]TdR  incorporation  were  determined  by  probit 
analysis; dilution values of the samples were divided by that of the standard  to provide 
the concentration of IL-2 in picomoles per liter. The standard IL-2 preparation routinely 
yielded 50% of maximal [3H]TdR incorporation at 6.25 pM. 
Radiolabeled  IL-2 Binding Assay.  Radiolabeled  IL-2 binding  to whole cells was per- 
formed as described in  detail previously (16).  All  cells  were prepared for the assay by 
centrifugation, followed by incubation at 37°C in IL-2-free RPMI  1640 medium for two 
l-h intervals, to facilitate dissociation and/or degradation of endogenously bound IL-2. 
These conditions were based upon the dissociation rate constant determined previously 
for intact cells and isolated plasma membranes (tv, for dissociation is 25 min) (16,  20). 
Serial dilutions of [ZH]leu,lys-IL-2 were incubated with ceils (10  ~ cells in 0.2 ml) in RPMI 
1640  medium supplemented  with  10%  FCS at 37°C.  After a  20-min incubation,  cold 
(0 ° C) R P M I 1640-FCS (1 ml) was added, and the cells were centrifuged. The supernatant 
containing the unbound fraction was removed and counted via liquid scintillation.  The 
cell pellet was resuspended in 0.1  ml cold RPMI and centrifuged through a 0.2-ml layer 
of a mixture of 85% silicone oil (Dexter Hysol 550 fluid; Dexter Corp., Orlean, NY) and 
15%  paraffin oil  (0-119;  Fisher  Scientific  Co.,  Fair  Lawn,  NJ).  The  tips  of the  tubes 
containing the cell pellet were cut off and counted by liquid scintillation to determine the 
level of bound radioactivity. The calculated values of the number of binding sites per cell 
were obtained by Scatchard analysis of equilibrium binding data, after subtraction of the 
nonspecific binding determined in the presence of 150-fold molar excess of unlabeled IL- 
2. The lower limit of detection of receptor sites per cell was 50. 
Flow Cytofluorometry.  Expression of T8 and T4 cell surface antigens was analyzed by 
flow  cytofluorometry. Cells  (10  ~ cells/ml)  were  incubated  (1  h,  4°C)  with  saturating 
concentrations of mAb, washed three times, and then incubated with a  1:40 dilution of 
fluorescein-conjugated rabbit anti-mouse Ig (Dakopatts; Accurate Chemical and Scientific 
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Ortho  Diagnostic  Systems,  Inc.,  Westwood,  MA)  using  an  argon  ion  laser  (Spectra- 
Physices, Inc., Mountain View, CA), at 488 nm excitation wavelength. Green fluorescence 
was observed using a 630-nm long-pass filter. A minimum of 10,000 cells, gated to exclude 
nonviable cells,  was accumulated for each histogram. All data were analyzed using the 
Ortho 2150 Data Handler System (Ortho Diagnostic Systems, Inc.), and the percentage 
of positive cells was calculated against a background of nonspecific labeling obtained using 
normal mouse IgG (1-3%). 
For analysis of the cellular DNA content of cells,  106 cells were labeled with the DNA- 
binding dye, propidium iodide (PI) (50 ug/ml; Calbiochem-Boehring Corp., La Joila, CA) 
in the presence of 100 Kunitz U/ml RNase (Sigma Chemical Co.), I. 12% sodium citrate, 
and 0.05% Nonidet P-40. The percentage of cells in the G0/G] phase of the cell cycle was 
estimated using the quick-estimate method of cell cycle analysis  provided with the 2150 
Data Handler software. 
[SH]TdR  Incorporation.  The proportion of S-phase cells  in various cell populations 
was estimated by monitoring [~H]TdR incorporation during 3-h culture intervals. Cultures 
were terminated by precipitation onto glass  fiber filters, and  were  cbunted by liquid 
scintillation.  Data are expressed as  cpm  [3H]TdR incorporated by  10  4 cells  placed in 
culture. 
IL-2 Metabolism.  Cell-mediated degradation of IL-2 was determined by allowing [3H]- 
leu,lys-IL-2 (75 pM) to bind to cells (8 x  105), and TCA (10%)-soluble and -precipitable 
radiolabel was determined at the intervals indicated. TCA-soluble radiolabel present at 
the initiation of the assays (2-5 %) was subtracted from those values obtained thereafter. 
Results 
Growth Characteristics of T4 + and  T8 + T  Cell Subsets.  IL-2-dependent growth 
of human PMC was promoted during a 72-h culture period with anti-T3, thereby 
initiating  IL-2 production and  IL-2-R  expression  in  situ.  The cells were  then 
washed and subcultured  in  125  pM  IL-2, a  concentration in fivefold excess of 
that required to saturate  high-affinity IL-2-R. Growth was maintained  for 10- 
12 d  by replenishment of IL-2 at 2-d intervals, when the cell concentration was 
reduced  10-fold  to  prevent  the  IL-2  concentration  from  becoming  growth- 
limiting.  Periodically, cell aliquots were removed and examined for expression 
of T4  and  T8  membrane  molecules  by immunocytofluorescence using  T  cell 
subset-specific mAb.  As illustrated  in  Fig.  1,  there is a  striking reversal of the 
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FIGURE  |.  T4/T8 Phenotypic analysis during IL-2-dependent growth.  PMC activated with 
anti-T3  (0.5 ng/ml) for 72 h were cultured  at 2-10 x  105 cells/ml in the presence of a 
saturating  concentration  of affinity-purified 1L-2 (125 pM;  replaced  where  indicated by 
arrows). The percentage of T4  + (1) and T8  + (A) cells was determined by cytofluorographic 
analysis. Data shown represent the mean +_ SEM of three separate experiments. 274  REGULATION  OF  T  CELL  AUTOCRINE  GROWTH 
T4+/T8 + ratio during a  12-d culture period, such that between day 5 and day 
12,  T8 +  cells  become  predominant,  and  eventually  comprise  >80%  of  the 
cultured cells. 
To explore the possibility that T8 + cells actively suppress the growth of T4 ÷ 
cells, the two subsets were cultured separately, using identical culture conditions. 
Homogeneous T4 + and T8 ÷ subpopulations were selected by antibody-depend- 
ent complement-mediated lysis using anti-T8 and anti-T4 at the start of culture, 
and again after 3 d. The cells were then maintained as before in purified IL-2, 
and  the  viable-cell  numbers  and  cell  surface  phenotypes  were  monitored  at 
regular intervals. A cumulative growth curve of unseparated cells and separated 
T4 + and T8 + subpopulations (Fig. 2) is especially illuminating, since it shows that 
isolated T4 + cells  cease  proliferation after  8  d  of culture,  whereas  T8 +  cells 
continue to expand exponentially for at least 3 d  more. Consequently, after 13 
d  of culture,  4.0  ×  l0 s T8 + cells accumulated, while T4 + cells had expanded 
only to about  6.5  x  10 7.  The  actual  increases  in  cell  numbers  that  occurred 
between day 3 and day 13 were 125-fold (unseparated cells), 106-fold (T8 + cells), 
and 27-fold (T4 + cells).  Consistent with these data, quantitative determination 
of cellular DNA content, using PI and cytofluorometric analysis (Fig. 3) revealed 
that by day 9, 90%  of T4 + cells had already reaccumulated in the G0/G1 phase 
of the cell cycle, whereas a  significant number of T8 + cells continued to cycle 
until day  13 of culture. Moreover, the earlier cessation of proliferation among 
the T4 + cells compared to T8 + cells was reflected by a  more  rapid decline in 
[3H]TdR  incorporation,  also  evident  in  Fig.  3.  Accordingly,  the  premature 
cessation of T4 + cell proliferation compared to T8 + cell proliferation cannot be 
attributed to any suppressive influence emanating from T8 + cells. 
IL-2-R  Expression  by T4 + vs.  T8 + Cells.  Results from our previous studies (6) 
using unseparated T  cells indicated that three variables determine the rate of T 
cell cycle progression;  IL-2 concentration, 1L-2-R density, and the duration of 
the IL-2-IL-2-R interaction.  Since the IL-2 concentration and the duration of 
exposure were identical in the experiments described on the isolated subsets, it 
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FIGURE  2.  IL-2-dependent growth of isolated T4/T8  subsets. Unseparated (O), T4 + (I), and 
T8 + (A) cells were cultured as in Fig. 1, and viable cell numbers were determined after the 
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FIGURE  3.  Cell cycle progression of isolated T4/T8 subsets during IL-2-dependent growth. 
[3H]TdR  incorporation  (closed  symbols) and  the  percent  G0/Gi  cells (open  symbols)  were 
determined on the T4 + (,) and T8 + (A) subsets shown in Fig. 2. 
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FIGURE 4.  Kinetics of IL-2-R expression by T4/T8  subsets. Anti-T3-activated unseparated 
cells (O), T4 + cells (II), and T8 + cells (A), were analyzed for high-affinity IL-2-R expression at 
the time intervals indicated. 
appeared likely that the premature cessation of T4 + cell growth was likely to be 
attributable  either  to quantitative  or  qualitative  differences in  the  IL-2-R  ex- 
pressed by T4 + vs. T8 ÷ cells. However, upon direct examination throughout the 
12-d culture period,  no differences were found in  the number of high-affinity 
IL-2-R expressed by T4 + and T8 ÷ cells (Fig. 4). Both subsets express IL-2 binding 
sites asynchronously and transiently after polyclonal anti-T3  activation,  so that 
the  kinetics  of  IL-2-R  appearance  and  disappearance  for  each  subset  were 
identical to those observed previously (5) for unseparated T  cells activated with 
PHA. 
To  examine  the  cell  subpopulations  for  differences  in  the  affinity  of the 
receptors  expressed  and  for  the  receptors'  functional  capacity  to  mediate  a 
proliferative response, cells were harvested from IL-2-dependent culture after 5 
d just before the cessation of T4 + cell growth.  Essentially identical radiolabeled 
IL-2  equilibrium  binding  curves were obtained,  yielding superimposable  Scat- 
chard plots (Fig.  5A). Moreover, the IL-2-R expressed by the separated subsets 
conveyed the IL-2 proliferative signal with equal efficiency, as evidenced by the 
symmetrical  sigmoid log-dose/response to varying concentrations  of IL-2  (Fig. 
5B). Thus, just before the time when T4 + cells cease to proliferate in response 276  REGULATION  OF  T  CELL  AUTOCR1NE  GROWTH 
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FIGURE  5.  IL-2-R expression and IL-2 biologic response of T4/T8  subsets determined after 
5  d  of culture.  (A) Equilibrium  [~H]leu,lys-IL-2 binding to T4 + cells (I) and T8 ÷ cells (&). 
Inset;  Scatchard plot.  (B)  Proliferative response of unseparated cells (Q),  T4 ÷ cells (11), and 
T8 + cells (&) 24 b after culture (105 cells/ml) with varying concentrations of immunoaffinity- 
purified IL-2. 
to IL-2, the number, affinity, and functional  response attributed to IL-2-R are 
identical to those of T8 ÷ cells, which continue to proliferate. 
IL-2 Metabolism.  In  previous experiments,  we (21) and  others (22,  23) had 
shown that cells expressing biologically active IL-2-R functioned to remove IL-2 
from culture medium in a time-, temperature-, and cell concentration-dependent 
fashion.  Subsequent findings  (Cantreli,  D.  A., and  K.  A.  Smith,  manuscript  in 
preparation)  have  shown  that  tbe depletion  of IL-2 activity from  the  culture 
medium is due to a  receptor-mediated  internalization  and degradation  of IL-2 
molecules that bind to the cells. Since T4 + cells ceased to respond to IL-2 before 
T8 + cells, the rate of degradation of radiolabeled IL-2 by the separated subpop- 
ulations was assessed. The cell-mediated conversion of [3H]leu,lys-IL-2 (75 pM) 
into a TCA-soluble form was analyzed with both subsets in exponential  growth 
(day 4), and when the two subpopulations differed in their proliferative response 
to IL-2 (day 8 and day  10 of culture).  The results, depicted in Fig. 6, attest to 
an  absence of any difference in  the  kinetics  of IL-2  degradation  mediated  by 
T4 + vs. T8 + cells, although IL-2 degradation  diminished as the culture intervals 
lengthened, and the mean density of high-affinity IL-2 binding sites decreased. 
The rate of radiolabeled IL-2 degradation was calculated from the data shown 
in  Fig.  6, and is given in Table I together with the number of IL-2-R/cell and 
the IL-2-dependent proliferative response of the separated cell populations for 
each time point monitored. Despite equivalent numbers of IL-2-R and equivalent GULLBERG AND  SMITH  277 
5.0 
E  z5 
E 
(Joy 4 
2,' 
O 
doy 8  50 
i  2  3  40  I  2  3  4  5  6  7  8 
hours of incubotion 
doy IO 
I  2  3  4  5  6  7  8 
FIGURE 6.  Degradation of [3H]leu,lys-IL-2  by T4/T8 subsets.  Unseparated cells (Q), T4  + 
cells (11), and T8  + cells (A) were examined at the time intervals indicated after 4, 8, and 10 d 
of culture for degradation of [~H]leu,lys-IL-2 (75 pM). 
TABLE  l 
Rate of lL-2 Degradation 
Cell  IL-2-R  IL-2 Degradation  [3H]TdR 
Day  population  (sites/cell)  (molecules/cell/h)  (cpm/104 cells) 
4  T8/T4  1,715  2,150  3,376 --- 291 
T8+  1,458  2,050  3,123 +  179 
T4+  1,728  1,950  3,258 + 76 
T8/T4  388  675  2,320 -  56 
T8+  388  625  1,872 + 94 
T4+  340  600  958 + 28 
10  T8/T4  322  550  2,170 + 69 
T8+  292  575  | ,584 + 57 
T4+  327  700  662 -  14 
Calculated  from results shown in Fig. 6. 
IL-2 degradation  rates for the two separate  subsets at each time point, by day 8 
of culture,  T4 + cell  [3H]TdR  incorporation  had  decreased  to  50%  that  of the 
T8 +  cells,  and  by  day  10,  T4 +  cell  proliferation  was  40%  of that  of the  T8 + 
population. 
T4 ÷ Cells Are Refractory to IL-2 Despite Adequate IL-2-R.  The  premature  loss 
of IL-2 responsiveness  by T4 + cells compared  with  T8 ÷ cells after  the primary 
activation with anti-T3  suggested that T4 + cells became refractory to continued 
IL-2 effects, and that this state  was unrelated  to IL-2-R interaction  or receptor- 
mediated  IL-2 internalization  and  metabolism.  To  substantiate  this  interpreta- 
tion,  and  to  investigate  whether  this  refractory  state  could  be  overcome  by 
reactivation of the T  celt antigen receptor complex, T4 + and T8 + cell subpopu- 
lations  were activated  with anti-T3  and cultured  with  IL-2 for  14 d,  as before. 
Subsequently,  stimulation  of  IL-2-R  reexpression  was  accomplished  by  a  6-h 
exposure  to  Pdbu  in  the absence  of accessory cells:  As shown  in  Fig.  7A,  20  h 
after  Pdbu  exposure,  T4 + cells  and  T8 +  cells  reexpressed  equivalent  levels  of 
high-affinity IL-2-R. However, as is evident in Fig. 7 B, only T8 ÷ cells proliferated 
in  response  to  IL-2.  Despite  continued  viability  throughout  the  succeeding  8 278  REGULATION  OF  T  CELL  AUTOCRINE  GROWTH 
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FIGURE  7.  Reexpression of IL-2-R and the IL-2 proliferative response of isolated T4/T8 
subsets. (A) Scatcbard plots of [3H]leu,lys-iL-2 equilibrium binding to T8 ÷ cells (A), and T4 ÷ 
ceils (rl) after  14 d  of culture; and to T8 + cells (A), and T4 + cells (11), 20 h  after activation 
with Pdbu (50 ng/m] for 6  h). (B) Proliferative response of the T4/T8 cell subsets shown in 
(A) to IL-2 (125 pM).  Cell concentrations were maintained between 2-10 x  103 cells/ml by 
subdivision every 2 d. 
days of recuhure, T4 + cells did not undergo morphologic blastogenesis, and the 
cell concentration remained stationary. 
Discussion 
Our results show that T4  + human T  cells differ substantially from T8 + cells 
with  respect  to  their  IL-2  responsiveness.  T4 + cells  cease  to  proliferate  well 
before T8 + cells  during a  primary response; moreover, upon restimulation of 
IL-2-R,  T4 +  cells  are  still  refractory  to  growth-promotion  by  IL-2.  As  no 
differences have been discerned between T4  + and T8 + cells in the rate, extent, 
or affinity of the IL-2-R expressed after a primary or secondary in vitro stimu- 
lation, the results suggest that T4 + cells become refractory to IL-2 at some point 
after IL-2-IL-2-R interaction. 
The various experimental approaches used here focused on the expression of 
high-affinity  (Ko,  5 pM), biologically relevant IL-2-R. We found previously (13) 
that IL-2 induces the expression of low-affinity (K,~,  5 nM) IL-2 binding sites via 
interaction with high-affinity IL-2-R. However, the functional relevance of the 
IL-2-induced low-affinity binding sites still  remains obscure, since saturation of 
these sites by raising the  IL-2 concentration  1,000-fold neither enhances nor 
retards the magnitude of the proliferative response observed when only the high- 
affinity IL-2-R are saturated (13, and other unpublished observations). 
To compare the IL-2-promoted proliferative response of T4 + cells  with T8 + 
cells, unfractionated peripheral mononuclear cells were chosen deliberately so as 
to avoid removing accessory cells required for optimal activation of the T  cell 
antigen receptor complex.  Thus,  the  in  vitro cell  population should have re- 
flected, as  closely as possible,  the cells  that are  likely to encounter antigen in 
vivo.  Moreover, anti-T3  was  selected as the initial activating ligand since it is 
now known (24,  25) that antigens activate T  cells  via interaction with a  90 kD GULLBERG AND  SMITH  279 
disulfide-linked heterodimer noncovalently  associated with three smaller proteins 
on the cell surface, the Ti-T3 complex. By using mAb reactive specifically with 
T3,  we hoped to activate all  mature T4  + and T8 + cells  and at the same time 
avoid stimulation of other surface structures that might affect the resulting IL- 
2-promoted response.  Consequently, it is especially noteworthy that both T4  + 
and T8 + cells express high-affinity IL-2-R at an equal rate, and, initially, prolif- 
erate in an identical fashion in response to IL-2 in situ, whether the two subsets 
have been cultured together or separately. 
Upon removal of anti-T3 and maintenance of the cells in homogeneous IL-2, 
the levels of high-affinity IL-2-R declined progressively, as reported previously 
(5) for cells activated initially with PHA. However, despite identical rates of IL- 
2-R decay and equivalent rates of IL-2 degradation mediated by T4  + vs.  T8  + 
cell populations, after 6  d  in culture, T4  + cell proliferation decelerated more 
rapidly than did T8 + cell proliferation. These results are particularly important 
because the IL-2-R levels at days 5 and 6  had decreased only to ~50%  of the 
maximum levels detected on day 3 of culture. Thus, the decline of IL-2 respon- 
siveness of T8  + cells follows, and is actually attributable to the disappearance of 
IL-2-R, whereas T4  + cells cease proliferation well before the IL-2-R decline to 
low levels. 
Although the mechanism of the T4  + cells' IL-2 refractoriness remains uncer- 
tain, it is clear that T4  + cells do not respond to IL-2 for some time after their 
initial response. Indeed, they remain refractory to IL-2 even after a  secondary 
restimultion of IL-2-R expression. It bears emphasis that adherent non-T cells 
are lost progressively during the initial 14-d  culture period while T  cells prolif- 
erate exponentially and the cells are passed to new culture flasks.  Consequently, 
by day 14, >99% of the cells are T  cells.  Although the progressive diminution 
of adherent non-T cells does not account for the observed differences in IL-2 
responsiveness of T4 + cells compared with T8 + cells,  it is conceivable that T4  + 
cells do  require accessory cells  for optimal  IL-2  responsiveness,  whereas  T8 + 
cells do not.  In  previous studies we (26)  and others (27,  28)  have noted that 
immune T  helper cells require accessory cells for optimal IL-2-dependent prolif- 
erative expansion and clonal isolation. In this respect, it may be significant that 
IL-2-R reexpression could be achieved even in  the absence of accessory cells, 
especially in view of reports (29) suggesting that accessory cells or their products 
(IL-1)  are  necessary  for  IL-2-R  expression,  and  for  acquisition  of the  IL-2- 
responsive  state  (29).  Rather,  from our  present  findings, it  seems  likely that 
accessory cells contribute to IL-2 responsiveness of T4 + cells not by facilitating 
expression of IL-2-R, but instead by promoting a cellular change necessary for 
activated IL-2-R to transmit signals required for progression through the cell 
cycle to DNA replication and mitosis. In that event, during an in vivo, antigen- 
initiated, IL-2-dependent T  cell proliferative response, the presence of a  fixed 
number  of accessory  cells  would  indeed  limit  the  extent  of T4 + cell  clonal 
expansion in a manner consistent with our observations in vitro. 
In considering further alternative mechanisms to account for T4 + cell  IL-2 
unresponsiveness, it is conceivable that physiologic inhibitory feedback signals 
are  generated via  the  IL-2-IL-2-R interaction itself.  At present,  we can  only 
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that  promote DNA replication.  However, we can categorize inhibitory mecha- 
nisms as those which operate through preexisting biochemical pathways, or those 
requiring specific gene expression. Regarding the latter, we have already shown 
that high-affinity  IL-2-R induce the expression of specific genes.  For example, 
the mechanism whereby IL-2 downregulates the expression of high-affinity IL- 
2-R involves the induction ofmRNA encoding low-affinity IL-2 binding proteins 
(13, 30-32).  Moreover, our recent studies (33) have shown that IL-2-promoted 
T  cell cycle progression  is preceded by the transient  expression of the cellular 
protooncogene, c-myb. It  will  be interesting  to compare  to  IL-2-induced  gene 
expression in T4 ÷ vs. T8 + cells, as this would allow us to determine whether an 
expressed gene promotes or inhibits subsequent DNA replication. 
The  difference  between  T4 + cells  and  T8 + cells  revealed  herein  must  be 
interpreted in the context of its significance for the development of an effective 
T  cell immune  response.  Within  T  cell populations,  T4 + cells are the primary 
source of IL-2 after antigen activation (11). Consequently, the finding that T4 + 
cell clonal  expansion  is only N25%  of the proliferative  expansion  achieved by 
T8 +  cells  indicates  that  IL-2  itself is  the  major  parameter  retarding  clonal 
expansion within the total cell population;  especially because the rate of T  cell 
proliferation  is directly dependent on the amount of IL-2 available to the cells. 
Thus, the immunologic relevance of the T4  + cell IL-2 refractory state resides in 
its potential as a feedback regulatory control retarding  the extent and duration 
of  IL-2-dependent  T4 ÷  and  T8 ÷  cell  clonal  expansion,  ensuring  that  IL-2- 
producing cells  ultimately  will  become limiting.  This  interpretation  is entirely 
consistent  with  our  previous  observations  (18,  21),  which  indicate  that  IL-2 
rapidly disappears from the culture medium of stimulated T  cells. Actually, the 
premature  development  of T4 +  cell  IL-2-unresponsiveness  would  have  gone 
undetected  had  we  not  ensured  experimentally  that  IL-2  could  not  become 
depleted in our culture system. Thus, two mechanisms contribute to the depletion 
of IL-2 from the  medium  of rapidly proliferating  T  cells:  IL-2  internalization 
and degradation  by responding cells, and cessation of T4 + (IL-2 producer) cell 
proliferative expansion. 
These results may have still further significance in view of the T4 + cell-tropism 
of the human T  lymphotropic viruses (HTLV). Although both HTLV-I/II (34, 
35) and  HTLV-III  (36,  37) can  enter  non-T4 + cells and  integrate  as proviral 
DNA, the pathologic effects of both types of viruses result primarily from their 
infection  of T4 ÷ cells.  HTLV-I,  the  etiologic agent  of adult  T  cell  leukemia 
(ATL) (38, 39), transforms T4 + cells preferentially. Cell lines derived from ATL 
patients  proliferate  independently  of added  IL-2 and  continuously  express an 
abnormally high density of IL-2-R (40).  It is possible that the neoplastic charac- 
teristics of ATL cells result from the abnormally high constitutive expression of 
IL-2-R. In addition, ATL cell lines may have lost the normal regulatory controls 
that ensure transient,  antigen-dependent expression of IL-2-R, as well as the IL- 
2 refractory state of T4 + cells described herein. 
The  dichotomy  between  T4 +  cells  and  T8 +  cells  manifested  by  an  IL-2 
refractory state may also be involved in the mechanism of the cytopathic effects 
of HTLV-III,  the etiologic agent of the acquired immunodeficiency syndrome 
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T8  + cells, additional studies directed at the mechanism of the IL-2 refractory 
state are surely warranted. Then too, since accessory cells could also be important 
determinants of the duration of T4  + cell  IL-2-responsiveness,  the finding that 
macrophages  are  easily  infected  by  HTLV-III  (Z.  Salahuddin  and  R.  Galio, 
personal communication) enhances the significance of our observations. Accord- 
ingly, it may be of considerable relevance that upon secondary stimulation T4* 
cells express IL-2-R, yet remain refractory to IL-2. IL-2-R  +, IL-2-unresponsive 
T4 ÷  cells  provide  a  unique  target  cell  system  for  studying  the  mechanisms 
responsible for the IL-2 refractory state and its immunobiologic consequences. 
Summary 
During the course of investigating the  regulation of IL-2-dependent T  cell 
proliferation,  we  found  that  the  subset  of human  T  cells  expressing  the  T4 
surface glycoprotein become refractory tO IL-2 growth promotion earlier than 
T8 + cells. Since T4 + cells proliferate in an autocrine fashion to endogenous IL- 
2, whereas most T8 ÷ cells respond in a  paracrine fashion to IL-2 derived from 
T4 + cells, we thought it likely that a  unique mechanism was operative to restrict 
T4 + cell IL-2-dependent autocrine proliferation. Moreover, we anticipated that 
the T4 + cell 1L-2-refractory state related either to suppression by T8 + cells, or 
to expression of T4 + cell IL-2-R. However, several experimental approaches did 
not support either of these mechanisms as being responsible for the loss of T4 + 
cell IL-2 responsiveness. Isolated T4 ÷ cells ceased to respond to IL-2 well before 
T8 + cells, and before the disappearance of adequate levels of IL-2-R. Moreover, 
a  detailed comparison  of IL-2-R  expression  by T4 + vs.  T8 ÷ cells revealed  no 
differences in the number, affinity, rate of expression, or functional activity of 
high-affinity IL-2-R expressed by the two subsets. Accordingly, T4 ÷ cell autocrine 
IL-2 responsiveness is restricted by a  mechanism that is independent of IL-2-R, 
and which ultimately results in cessation of both T4 + and T8 + cell IL-2-dependent 
c[onal expansion. 
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